Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2005-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BBAPAP.2005.04.008PMID 15964788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics and mechanism of the reaction of cysteine and hydrogen peroxide in aqueous solution.

  2005cited by this paper
• Distribution and ultrastructure of Alzheimer's neurofibrillary tangles in postencephalitic parkinsonism of Economo type

  2004cited by this paper
• H2O2-induced Intermolecular Disulfide Bond Formation between Receptor Protein-tyrosine Phosphatases*

  2004cited by this paper
• Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control

  2004cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Effects induced by hydroxyl radicals on salmon calcitonin: a RP-HPLC, CD and TEM study.

  2003cited by this paper
• Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid

  2003cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Preparation and evaluation of proliposomes containing salmon calcitonin.

  2002cited by this paper
• Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies

  2002cited by this paper
• Routine preparation of air-dried negatively stained and unstained specimens on holey carbon support films: a review of applications.

  2002cited by this paper
• Radical formation at Tyr39 and Tyr153 following reaction of yeast cytochrome c peroxidase with hydrogen peroxide.

  2002cited by this paper
• P-glycoprotein inserted in planar lipid bilayers formed by liposomes opened on amorphous carbon and Langmuir-Blodgett monolayer.

  2002cited by this paper
• Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.

  2001cited by this paper
• Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer’s disease

  2001cited by this paper
• Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes.

  2000cited by this paper
• DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs.

  2000cited by this paper
• Solution stability of salmon calcitonin at high concentration for delivery in an implantable system.

  2000cited by this paper
• Reactive oxygen species: oxidative damage and pathogenesis

  1999cited by this paper
• A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal fragments of human and salmon calcitonin.

  1998cited by this paper
• Mechanochemical mechanism for peptidyl free radical generation by amyloid fibrils

  1997cited by this paper
• Phosphatydylglycerol promotes bilayer insertion of salmon calcitonin.

  1997cited by this paper
• Oxidative Stress and Aging

  1995cited by this paper
• Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin.

  1995cited by this paper
• Electron Energy-Loss Spectroscopy in the Electron Microscope

  1995cited by this paper
• Amyloid peptides are toxic via a common oxidative mechanism.

  1995cited by this paper
• Enhanced potency of human calcitonin when fibrillation is avoided.

  1995cited by this paper
• Oxidative damage in neurodegenerative disease.

  1994cited by this paper
• Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

  1994cited by this paper
• Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy.

  1994cited by this paper
• Multiple conformations and proline cis-trans isomerization in salmon calcitonin: a combined nuclear magnetic resonance, distance geometry, and molecular mechanics study.

  1994cited by this paper
• Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.

  1994cited by this paper
• Amyloid formation by salmon calcitonin.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• The structure and mechanism of formation of human calcitonin fibrils.

  1993cited by this paper
• Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.

  1993cited by this paper
• Free radicals, antioxidants, and human disease: where are we now?

  1992cited by this paper
• Straight and paired helical filaments in Alzheimer disease have a common structural unit.

  1991cited by this paper
• Solution structure of salmon calcitonin

  1991cited by this paper
• Dominant forces in protein folding.

  1990cited by this paper
• Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits.

  1990cited by this paper
• The Calcitonins: Physiology and Pharmacology

  1989cited by this paper
• Sequential 1H NMR assignment and secondary structure determination of salmon calcitonin in solution.

  1989cited by this paper
• Peptides from the calcitonin genes: molecular genetics, structure and function.

  1988cited by this paper
• Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.

  1983cited by this paper
• Amphipathic helix and its relationship to the interaction of calcitonin with phospholipids.

  1983cited by this paper
• Kinetic studies on photolysis-induced gelation of sickle cell hemoglobin suggest a new mechanism.

  1980cited by this paper
• Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli.

  1968cited by this paper

• Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants

  2022cites this paper
• Construction of Active Protein Materials: Manipulation on Morphology of Salmon Calcitonin Assemblies with Enhanced Bone Regeneration Effect

  2022cites this paper
• Evaluating parameters affecting drug fate at the intramuscular injection site.

  2021cites this paper
• Design and Characterizations of Inhalable Poly(lactic-co-glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin

  2020cites this paper
• Role of Pre-molten Globule Structure in Protein Amyloid Fibril Formation

  2019cites this paper
• Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.

  2019cites this paper
• Oxidatively-mediated in silico epimerization of a highly amyloidogenic segment in the human calcitonin hormone (hCT15-19)

  2019cites this paper
• Development of a polysaccharide based multi-unit nanofiber mat for colon-targeted sustained release of salmon calcitonin.

  2019cites this paper
• Pentapeptide-decorated silica nanoparticles loading salmon calcitonin for in vivo osteoporosis treatment with sustained hypocalcemic effect

  2019cites this paper
• The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca2+-Influx and Neurotoxicity

  2019cites this paper
• Rational Design of Liquid Formulations of Proteins.

  2018cites this paper
• Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time

  2017cites this paper
• Factors affecting the physical stability (aggregation) of peptide therapeutics

  2017cites this paper
• Structural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation

  2017cites this paper
• Monosialoganglioside-GM1 triggers binding of the amyloid-protein salmon calcitonin to a Langmuir membrane model mimicking the occurrence of lipid-rafts

  2016cites this paper
• Salmon calcitonin: conformational changes and stabilizer effects

  2015cites this paper
• Amyloid Proteins : A Large Family of Unrelated Proteins with Some Shared Features

  2014cites this paper
• Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS.

  2014cites this paper
• Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences

  2013cites this paper
• Influence of methionine oxidation on the aggregation of recombinant human growth hormone.

  2013cites this paper
• NMR investigations of structural and dynamics features of natively unstructured drug peptide – salmon calcitonin: implication to rational design of potent sCT analogs

  2013cites this paper
• Protein Oxidation and Aging: Different Model Systems and Affecting Factors

  2012cites this paper
• Metal ions as cofactors for aggregation of therapeutic peptide salmon calcitonin.

  2012cites this paper
• Investigations into the Fate of Inhaled Salmon Calcitonin at the Respiratory Epithelial Barrier

  2011cites this paper
• Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts

  2011cites this paper
• The Slowly Aggregating Salmon Calcitonin: A Useful Tool for the Study of the Amyloid Oligomers Structure and Activity

  2011cites this paper
• Chemical Instability in Peptide and Protein Pharmaceuticals

  2010cites this paper
• Lipid raft disruption protects mature neurons against amyloid oligomer toxicity.

  2010cites this paper
• Stability of Protein Pharmaceuticals: An Update

  2010cites this paper
• Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

  2009cites this paper
• Encapsulation of fluorogenic probes and pharmacologically active molecules into nanoparticles for enhancing cellular uptake

  2009cites this paper
• Amyloidogenesis of natively unfolded proteins.

  2008cites this paper
• Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin

  2008cites this paper
• Calcitonin forms oligomeric pore-like structures in lipid membranes.

  2006cites this paper